Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Prevalence of comorbidities in deceased patients with COVID-19: A systematic review
Dayane Caroliny Pereira Justino1, David Franciole Oliveira Silva1, Ketyllem Tayanne da Silva Costa2
1Department of Public Health, Federal University of Rio Grande do Norte, Brazil.
Insights
This systematic review found that a significant percentage of patients who died from coronavirus disease (COVID-19) had pre-existing chronic non-transmissible diseases. Hypertension and diabetes were the most common comorbidities observed in deceased COVID-19 patients.
Area of Science:
- Medical Research
- Epidemiology
- Public Health
Background:
- The emergence of coronavirus disease (COVID-19) in December 2019 necessitated understanding its pathogenesis.
- Key factors influencing COVID-19 progression, particularly in relation to chronic conditions, remained unclear.
Purpose of the Study:
- To systematically review existing literature on the association between COVID-19 infection and chronic non-transmissible diseases in patients who died from the disease.
Main Methods:
- A systematic literature review was conducted, analyzing observational studies published from December 2019 to September 2020.
- The review protocol was registered with PROSPERO (CRD42020176249).
Main Results:
- Analysis of 31 studies included 421,872 COVID-19 patients, with 45,399 (10.8%) fatalities.
- Hypertension, diabetes mellitus, and respiratory diseases were the most prevalent comorbidities among all patients.
- The overall cure/recovery rate was 89.2% (376,473 patients).
Conclusions:
- A high prevalence of comorbidities was observed in COVID-19 patients.
- Comorbidities were particularly pronounced in patients who succumbed to COVID-19.
Background:
In December 2019, a new disease, coronavirus disease (COVID-19), emerged, which put several countries on a state of alert. Because it is a novel virus, several aspects and factors that contribute to the evolution of pathogenesis are still unknown and need to be better understood. Therefore, a systematic review is necessary to investigate the association between COVID-19 infection and chronic nontransmissible disease in patients who have died of COVID-19.
Methods:
This was a systematic review of the literature for observational studies published between December 2019 and September 2020. The protocol for this systematic review was registered in the International prospective register of systematic reviews (PROSPERO) under the number CRD42020176249.
Results:
In the 31 studies analyzed, a total of 421,872 (100%) patients were infected with COVID-19, and, of these, 45,399 (10.8%) died. The 3 most prevalent comorbidities were hypertension, diabetes mellitus, and respiratory diseases, respectively. The cure/recovery rate was 89.2% (376,473).
Conclusion:
This review revealed a high percentage of comorbidities in the patients with COVID-19, especially those who died.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia III: Complications and Assessment
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations